BCL2L11 and postmenopausal osteoporosis: Indeed, miRNA targets bcl-2-like protein 11 (BIM), a pro-apoptotic factor, hence preventing osteoblast cell death; conversely, estrogen deprivation (e.g., OVX and postmenopausal osteoporosis) leads to pro-apoptotic BIM upregulation [40].